Due to the time needed to resolve the cross-cutting issues and then select and prepare a group of early cases for trial, the first GLP-1 lawsuits are unlikely to go before federal juries until at least 2027
M., & Olin, J
For example: Fatigue, unexplained weight loss, or abdominal pain may indicate liver disease or cancer Easy bruising, night sweats, or feeling full quickly (early satiety) may suggest a myeloproliferative disorder Swelling in the legs, reduced urine output, or persistent nausea may point to kidney disease In cases of very high B12 from injections (not oral supplements), some people have reported headache, nausea, diarrhea, facial flushing, or skin rash
Obtaining, supplying, or using retatrutide outside of an authorised clinical trial or other formally regulated research setting is inappropriate and may be unlawful in the UK